Ming O. Li Immunology Program, Memorial Sloan Kettering Cancer Center, USA

Home

Archive

About Us

Ruth Franklin Yale University
1 protocol

Michael Zhang Molecular and Cellular Biology Department, University of Texas at Dallas, USA
2 protocols

Will Liao Genomics, New York Genome Center, USA
2 protocols

Weiming Ouyang Center for Drug Evaluation and Research, U.S. Food and Drug Administration, USA
2 protocols

Ming O. Li

Immunology Program, Memorial Sloan Kettering Cancer Center, USA

Research focus

Immunology

3 Author merit
Reviewer merit
Editor merit

3 Protocols published

Determining Leukocyte Origins Using Parabiosis in the PyMT Breast Tumor Model

Authors: Ruth A. Franklin and Ming O. Li, date: 08/20/2015, view: 8933, Q&A: 0

Tumors develop in a complex microenvironment alongside numerous cell types that impact their survival. Immune cells make up a large proportion of these accessory cells and many are known to promote tumor progression. Macrophages, in particular, are ...

More >

Murine in vivo CD8⁺ T Cell Killing Assay

Authors: Myoungjoo V. Kim, Weiming Ouyang, Will Liao, Michael Q. Zhang and Ming O. Li, date: 07/05/2014, view: 17292, Q&A: 0

Antigen-specific killing ability of effector CD8⁺ T cells is critical for protective immunity against infection. Here, we describe in vivo cytotoxic T cell assay to examine effector function of antigen-specific CD8⁺ T ...

More >

More protocols >